ORTEXORTEX News
Tracking SLV? Get live short interest, options flow, and signals on ORTEX.Sign up free →
SL
Trader NoteSLV

Silver's Borrow Market Snaps Back as SLV Rallies 5.6%

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 23 Sept 2026, 19:19

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

SLV enters the back half of September with a sharp price recovery colliding with an equally sharp reversal in its lending market — creating one of the more interesting setups the iShares Silver Trust has seen in months.

The week's standout story is in availability. After spending much of mid-September in genuinely tight territory — availability dropped to around 47-50% between September 10 and 16, meaning barely one share was available to borrow for every two already lent out — the lending pool has opened back up dramatically. Availability has now risen to 138%, nearly three times where it sat at the tightest point just a week ago. The 52-week low availability reading was 9.75%, so the current level is hardly loose by the standards of the past year, but the direction of travel has flipped decisively. Short interest eased 3.4% over the week to 5.9% of free float, pulling back from a spike that had pushed the one-month change to a substantial 31%. The cost to borrow remains low at 0.70% — up about 6% on the week but still well within the range it has traded across August and September. Borrow conditions are normalising, not tightening.

Options positioning tells a relatively calm story alongside that. The put/call ratio is running at 0.44, fractionally below its 20-day average of 0.45 and a half-standard-deviation below the mean — essentially neutral. There is no unusual demand for downside protection here. The 52-week PCR range spans 0.39 to 0.85, placing the current reading toward the call-heavy end of the historical distribution. That broadly aligns with a market that has been adding to call exposure as silver prices rally, rather than hedging against a reversal.

What makes the week's data worth watching is the sequence: availability tightened to near-critical levels in the September 10-16 window — the period when SLV was still trading through its one-month decline of around 3% — and short interest simultaneously ran up 31% over the month. Then silver bounced, up 5.6% on the week to close at $60.73. Short positions eased 3.4%, and availability snapped back. The ORTEX short score has also retreated, falling from 58-59 last week to 56.1 now, consistent with the ebbing of short conviction. Whether the squeeze dynamic was mechanical or fundamental, the lending data suggests shorts were caught leaning the wrong way into the rally.

Institutional flow offers some context. Morgan Stanley is the largest disclosed holder at roughly 2.5% of shares, and added about 1.25 million shares through Q2. Goldman Sachs added the most aggressively among the large names, building by 1.7 million shares in the same period. Jane Street — typically a liquidity-driven participant — trimmed by 2.2 million shares. The picture is broadly constructive on the demand side, with banks and asset managers adding exposure rather than reducing it into what was a softer pricing environment in late summer.

The next thing to watch is whether availability holds at these more comfortable levels or tightens again if silver extends its rally — history from mid-September shows that price strength and borrow tightness can coincide quickly in this ETF.

Stocks in this article

See the live data behind this article on ORTEX.

Open SLV on ORTEX →

How this article was generated

Generated
23 Sept 2026, 19:26
Data as of
23 Sept 2026, 19:19
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.